CTH and rheumatoid arthritis: Collectively, these data demonstrate that HDAC6 promotes RA, and SPRC inhibits HDAC6- and NF-κB-related pro-RA genes, exhibiting an anti-RA effect by enhancing CSE expression in vivo.